CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $269,615 | -45.0% | 46,167 | -36.8% | 0.00% | -33.3% |
Q3 2022 | $490,000 | +29.3% | 73,068 | -18.9% | 0.00% | +50.0% |
Q2 2022 | $379,000 | +871.8% | 90,123 | +635.5% | 0.00% | – |
Q4 2021 | $39,000 | -26.4% | 12,254 | -1.6% | 0.00% | -100.0% |
Q2 2021 | $53,000 | -72.1% | 12,452 | -67.4% | 0.00% | -50.0% |
Q1 2021 | $190,000 | +900.0% | 38,151 | +2441.7% | 0.00% | – |
Q4 2020 | $19,000 | -32.1% | 1,501 | -46.7% | 0.00% | – |
Q3 2020 | $28,000 | +2700.0% | 2,817 | +2929.0% | 0.00% | – |
Q2 2020 | $1,000 | -99.5% | 93 | -99.5% | 0.00% | -100.0% |
Q2 2019 | $219,000 | +69.8% | 18,235 | +70.9% | 0.00% | 0.0% |
Q1 2019 | $129,000 | -72.8% | 10,672 | -41.8% | 0.00% | -84.0% |
Q4 2017 | $474,000 | +577.1% | 18,324 | +287.5% | 0.02% | +525.0% |
Q3 2017 | $70,000 | +288.9% | 4,729 | +165.2% | 0.00% | +300.0% |
Q3 2016 | $18,000 | +38.5% | 1,783 | +57.2% | 0.00% | 0.0% |
Q2 2016 | $13,000 | -67.5% | 1,134 | -61.4% | 0.00% | -50.0% |
Q1 2016 | $40,000 | -51.2% | 2,938 | -46.4% | 0.00% | -50.0% |
Q2 2015 | $82,000 | +8100.0% | 5,486 | +6431.0% | 0.00% | – |
Q1 2015 | $1,000 | -99.5% | 84 | -99.4% | 0.00% | -100.0% |
Q4 2014 | $185,000 | – | 13,866 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |